Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
451 | 16125 | 24.2 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | journal | 425807 | 10% | 14% | 1676 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | journal | 261665 | 11% | 8% | 1810 |
3 | CHEMOTHERAPY-TOKYO | journal | 227551 | 1% | 80% | 150 |
4 | MEROPENEM | authKW | 187693 | 1% | 46% | 217 |
5 | PHARMACOLOGY & PHARMACY | WoSSC | 133662 | 53% | 1% | 8531 |
6 | CEFEPIME | authKW | 126166 | 1% | 45% | 148 |
7 | DORIPENEM | authKW | 123789 | 1% | 74% | 89 |
8 | CHEMOTHERAPY | journal | 121963 | 3% | 16% | 405 |
9 | MICROBIOLOGY | WoSSC | 103519 | 34% | 1% | 5459 |
10 | INFECTIOUS DISEASES | WoSSC | 102352 | 24% | 1% | 3879 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 133662 | 53% | 1% | 8531 |
2 | Microbiology | 103519 | 34% | 1% | 5459 |
3 | Infectious Diseases | 102352 | 24% | 1% | 3879 |
4 | Chemistry, Analytical | 3244 | 8% | 0% | 1215 |
5 | Medicine, General & Internal | 2934 | 8% | 0% | 1268 |
6 | Immunology | 1011 | 6% | 0% | 922 |
7 | Medical Laboratory Technology | 691 | 1% | 0% | 217 |
8 | Critical Care Medicine | 581 | 2% | 0% | 247 |
9 | Toxicology | 558 | 3% | 0% | 415 |
10 | Pediatrics | 496 | 3% | 0% | 480 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BURNS TRAUMA CRIT CARE | 99359 | 1% | 35% | 152 |
2 | CLIN PHARMACOTHER Y | 38739 | 0% | 50% | 41 |
3 | ANTIINFECT DEV | 36294 | 0% | 27% | 71 |
4 | ANTI INFECT DEV | 16333 | 0% | 41% | 21 |
5 | ANTIBIOL | 9438 | 0% | 33% | 15 |
6 | ADC T | 8055 | 0% | 47% | 9 |
7 | BASIL HETZEL TRANSLAT HLTH | 6968 | 0% | 31% | 12 |
8 | PHARM | 6505 | 6% | 0% | 1044 |
9 | MED PL PHARMACOKINET | 6052 | 0% | 80% | 4 |
10 | CREPIT | 5675 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 425807 | 10% | 14% | 1676 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 261665 | 11% | 8% | 1810 |
3 | CHEMOTHERAPY-TOKYO | 227551 | 1% | 80% | 150 |
4 | CHEMOTHERAPY | 121963 | 3% | 16% | 405 |
5 | JAPANESE JOURNAL OF ANTIBIOTICS | 64856 | 0% | 70% | 49 |
6 | INFECTION | 51505 | 2% | 9% | 321 |
7 | REVIEWS OF INFECTIOUS DISEASES | 44404 | 2% | 10% | 245 |
8 | PATHOLOGIE BIOLOGIE | 37251 | 2% | 7% | 294 |
9 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 36000 | 1% | 10% | 188 |
10 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 25898 | 2% | 5% | 272 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEROPENEM | 187693 | 1% | 46% | 217 | Search MEROPENEM | Search MEROPENEM |
2 | CEFEPIME | 126166 | 1% | 45% | 148 | Search CEFEPIME | Search CEFEPIME |
3 | DORIPENEM | 123789 | 1% | 74% | 89 | Search DORIPENEM | Search DORIPENEM |
4 | ERTAPENEM | 96469 | 1% | 52% | 99 | Search ERTAPENEM | Search ERTAPENEM |
5 | PIPERACILLIN | 74644 | 1% | 44% | 90 | Search PIPERACILLIN | Search PIPERACILLIN |
6 | CEPHALOSPORINS | 72527 | 1% | 18% | 209 | Search CEPHALOSPORINS | Search CEPHALOSPORINS |
7 | CARBAPENEMS | 69914 | 1% | 22% | 170 | Search CARBAPENEMS | Search CARBAPENEMS |
8 | CEFPIROME | 61761 | 0% | 73% | 45 | Search CEFPIROME | Search CEFPIROME |
9 | CEFTAZIDIME | 60102 | 1% | 27% | 118 | Search CEFTAZIDIME | Search CEFTAZIDIME |
10 | TAZOBACTAM | 54334 | 0% | 50% | 57 | Search TAZOBACTAM | Search TAZOBACTAM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | EL-SHABOURY, SR , SALEH, GA , MOHAMED, FA , RAGEH, AH , (2007) ANALYSIS OF CEPHALOSPORIN ANTIBIOTICS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 45. ISSUE 1. P. 1-19 | 193 | 89% | 64 |
2 | SIME, FB , ROBERTS, MS , PEAKE, SL , LIPMAN, J , ROBERTS, JA , (2012) DOES BETA-LACTAM PHARMACOKINETIC VARIABILITY IN CRITICALLY ILL PATIENTS JUSTIFY THERAPEUTIC DRUG MONITORING? A SYSTEMATIC REVIEW.ANNALS OF INTENSIVE CARE. VOL. 2. ISSUE . P. - | 94 | 87% | 33 |
3 | CIELECKA-PIONTEK, J , MICHALSKA, K , ZALEWSKI, P , ZASADA, S , (2012) COMPARATIVE REVIEW OF ANALYTICAL TECHNIQUES FOR DETERMINATION OF CARBAPENEMS.CURRENT ANALYTICAL CHEMISTRY. VOL. 8. ISSUE 1. P. 91-115 | 101 | 91% | 5 |
4 | BREILH, D , TEXIER-MAUGEIN, J , ALLAOUCHICHE, B , SAUX, MC , BOSELLI, E , (2013) CARBAPENEMS.JOURNAL OF CHEMOTHERAPY. VOL. 25. ISSUE 1. P. 1-17 | 109 | 76% | 14 |
5 | GRUPPER, M , KUTI, JL , NICOLAU, DP , (2016) CONTINUOUS AND PROLONGED INTRAVENOUS BETA-LACTAM DOSING: IMPLICATIONS FOR THE CLINICAL LABORATORY.CLINICAL MICROBIOLOGY REVIEWS. VOL. 29. ISSUE 4. P. 759 -772 | 96 | 86% | 0 |
6 | ROBERTS, JA , LIPMAN, J , (2006) ANTIBACTERIAL DOSING IN INTENSIVE CARE - PHARMACOKINETICS, DEGREE OF DISEASE AND PHARMACODYNAMICS OF SEPSIS.CLINICAL PHARMACOKINETICS. VOL. 45. ISSUE 8. P. 755-773 | 122 | 67% | 99 |
7 | BALANT, L , DAYER, P , AUCKENTHALER, R , (1985) CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS.CLINICAL PHARMACOKINETICS. VOL. 10. ISSUE 2. P. 101-143 | 211 | 93% | 94 |
8 | GONCALVES-PEREIRA, J , POVOA, P , (2011) ANTIBIOTICS IN CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW OF THE PHARMACOKINETICS OF BETA-LACTAMS.CRITICAL CARE. VOL. 15. ISSUE 5. P. - | 74 | 86% | 87 |
9 | BOYER, A , GRUSON, D , BOUCHET, S , CLOUZEAU, B , BUI, HN , VARGAS, F , GILLES, H , MOLIMARD, M , ROGUES, AM , MOORE, N , (2013) AMINOGLYCOSIDES IN SEPTIC SHOCK.DRUG SAFETY. VOL. 36. ISSUE 4. P. 217-230 | 101 | 66% | 16 |
10 | SCAGLIONE, F , PARABONI, L , (2008) PHARMACOKINETICS/PHARMACODYNAMICS OF ANTIBACTERIALS IN THE INTENSIVE CARE UNIT: SETTING APPROPRIATE DOSING REGIMENS.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 32. ISSUE 4. P. 294 -U19 | 131 | 56% | 50 |
Classes with closest relation at Level 2 |